Marta Marszałek-Grabska

Dr. Marta Marszałek-Grabska

Department of Experimental and Clinical Pharmacology, Medical University of Lublin, 20-059 Lublin, Poland
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2018 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Open access
PDF file
KGKinga Gawel
Kinga Gawel
EGEwa Gibuła-Tarłowska
Ewa Gibuła-Tarłowska
Marta Marszałek-GrabskaMarta Marszałek-Grabska
Marta Marszałek-Grabska
JFJoanna Filarowska
Joanna Filarowska
Jolanta H. KotlinskaJolanta H. Kotlinska
Jolanta H. Kotlinska
Among the methods valuable for assessing spatial learning and memory impairments in rodents, the Barnes maze (BM) task deserves special attention. It is based on the assumption that the animal placed into the aversive environment should learn and remember the location of an escape box located below the surface of the platform. Different phases of the task allow to measure spatial learning, memory retrieval, and cognitive flexibility. Herein, we summarize current knowledge about the BM procedure, its variations and critical parameters measured in the task. We highlight confounding factors which should be taken into account when conducting BM task, discussing briefly its advantages and disadvantages. We then propose an extended version of the BM protocol which allows to measure different aspects of spatial learning and memory in rodents. We believe that this review will help to standardize the BM methodology across the laboratories and eventually make the results comparable.

4 July 2016 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Open access
PDF file
KGKinga Gawel
Kinga Gawel
KLKrzysztof Labuz
Krzysztof Labuz
EGEwa Gibuła-Tarłowska
Ewa Gibuła-Tarłowska
MJMalgorzata Jenda
Malgorzata Jenda
Marta Marszałek-GrabskaMarta Marszałek-Grabska
Marta Marszałek-Grabska
Jolanta H. KotlinskaJolanta H. Kotlinska
Jolanta H. Kotlinska
Central cholinergic dysfunction contributes to acute spatial memory deficits produced by ethanol administration. Donepezil and rivastigmine elevate acetylcholine levels in the synaptic cleft through the inhibition of cholinesterases—enzymes involved in acetylcholine degradation. The aim of our study was to reveal whether donepezil (acetylcholinesterase inhibitor) and rivastigmine (also butyrylcholinesterase inhibitor) attenuate spatial memory impairment as induced by acute ethanol administration in the Barnes maze task (primary latency and number of errors in finding the escape box) in rats. Additionally, we compared the influence of these drugs on ethanol-disturbed memory. In the first experiment, the dose of ethanol (1.75 g/kg, i.p.) was selected that impaired spatial memory, but did not induce motor impairment. Next, we studied the influence of donepezil (1 and 3 mg/kg, i.p.), as well as rivastigmine (0.5 and 1 mg/kg, i.p.), given either before the probe trial or the reversal learning on ethanol-induced memory impairment. Our study demonstrated that these drugs, when given before the probe trial, were equally effective in attenuating ethanol-induced impairment in both test situations, whereas rivastigmine, at both doses (0.5 and 1 mg/kg, i.p.), and donepezil only at a higher dose (3 mg/kg, i.p.) given prior the reversal learning, attenuated the ethanol-induced impairment in cognitive flexibility. Thus, rivastigmine appears to exert more beneficial effect than donepezil in reversing ethanol-induced cognitive impairments—probably due to its wider spectrum of activity. In conclusion, the ethanol-induced spatial memory impairment may be attenuated by pharmacological manipulation of central cholinergic neurotransmission.

1 February 2018 in Behavioural Brain Research
Verified
Journal Article
Closed access
Marta Marszałek-GrabskaMarta Marszałek-Grabska
Marta Marszałek-Grabska
EGEwa Gibuła-Tarłowska
Ewa Gibuła-Tarłowska
ABAnna Bodzon-Kulakowska
Anna Bodzon-Kulakowska
PSPiotr Suder
Piotr Suder
KGKinga Gawel
Kinga Gawel
Jolanta H. KotlinskaJolanta H. Kotlinska
Jolanta H. Kotlinska

2 August 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BPBruno Pedraz
Bruno Pedraz
Marta Marszałek-GrabskaMarta Marszałek-Grabska
Marta Marszałek-Grabska
AKAnna Kozub
Anna Kozub
KSKlaudia Szalaj
Klaudia Szalaj
ATAlicja Trzpil
Alicja Trzpil
EFEmilia Fornal
Emilia Fornal
Tryptophan breakdown metabolites formed along the kynurenine pathway play a significant role in pregnancy and fetal development. To understand their involvement, it is crucial to quantify the levels of tryptophan (TRP), kynurenine (KYN), and kynurenic acid (KYNA) in relevant biological samples such as the placenta, fetal membranes, and umbilical cord. This study used liquid chromatography-tandem mass spectrometry (LC–MS/MS) to determine TRP, KYN, and KYNA levels. The LC–MS/MS method was optimized for high sensitivity and specificity, demonstrating good reproducibility with a precision of < 10% CV and an accuracy of 85–115%. The lower limit of quantification for both TRP and KYN was 0.5 µg/ml, while for KYNA, it was 0.5 ng/mL. The method exhibited linearity within the examined range of concentrations in the homogenate, ranging from 0.5 to 30 µg/ml for TRP and KYN and from 0.5 to 25 ng/ml for KYNA. Using this method, we found significant differences in the concentrations of these substances in investigated maternal–fetal compartments. Placenta samples exhibited higher KYN and lower KYNA concentrations than the umbilical cord and fetal membrane, indicating a potentially important role for kynurenines in late pregnancy. Collectively, this finding may facilitate further research and provide inside into the involvement of the kynurenine pathway of TRP metabolism in fetal development.

1 July 2017 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
ABAnna Bodzon-Kulakowska
Anna Bodzon-Kulakowska
AAAnna Antolak
Anna Antolak
ADAnna Drabik
Anna Drabik
Marta Marszałek-GrabskaMarta Marszałek-Grabska
Marta Marszałek-Grabska
Jolanta H. KotlinskaJolanta H. Kotlinska
Jolanta H. Kotlinska
PSPiotr Suder
Piotr Suder

Verified
Journal Article
Open access
PDF file
PGPawel Grochecki
Pawel Grochecki
ISIrena Smaga
Irena Smaga
MLMałgorzata Lopatynska-Mazurek
Małgorzata Lopatynska-Mazurek
EGEwa Gibuła-Tarłowska
Ewa Gibuła-Tarłowska
EKEwa Kędzierska
Ewa Kędzierska
Jolanta H. KotlinskaJolanta H. Kotlinska
Jolanta H. Kotlinska
A synthetic cathinone, mephedrone is widely abused by adolescents and young adults. Despite its widespread use, little is known regarding its long-term effects on cognitive function. Therefore, we assessed, for the first time, whether (A) repeated mephedrone (30 mg/kg, i.p., 10 days, once a day) exposure during adolescence (PND 40) induces deleterious effects on spatial memory and reversal learning (Barnes maze task) in adult (PND 71–84) rats and whether (B) these effects were comparable to amphetamine (2.5 mg/kg, i.p.). Furthermore, the influence of these drugs on MMP-9, NMDA receptor subunits (GluN1, GluN2A/2B) and PSD-95 protein expression were assessed in adult rats. The drug effects were evaluated at doses that per se induce rewarding/reinforcing effects in rats. Our results showed deficits in spatial memory (delayed effect of amphetamine) and reversal learning in adult rats that received mephedrone/amphetamine in adolescence. However, the reversal learning impairment may actually have been due to spatial learning rather than cognitive flexibility impairments. Furthermore, mephedrone, but not amphetamine, enhanced with delayed onset, MMP-9 levels in the prefrontal cortex and the hippocampus. Mephedrone given during adolescence induced changes in MMP-9 level and up-regulation of the GluN2B-containing NMDA receptor (prefrontal cortex and hippocampus) in young adult (PND 63) and adult (PND 87) rats. Finally, in adult rats, PSD-95 expression was increased in the prefrontal cortex and decreased in the hippocampus. In contrast, in adult rats exposed to amphetamine in adolescence, GluN2A subunit and PSD-95 expression were decreased (down-regulated) in the hippocampus. Thus, in mephedrone—but not amphetamine-treated rats, the deleterious effects on spatial memory were associated with changes in MMP-9 level. Because the GluN2B-containing NMDA receptor dominates in adolescence, mephedrone seems to induce more harmful effects on cognition than amphetamine does during this period of life.